Rhumbline Advisers Merck & Co., Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 4,463,320 shares of MRK stock, worth $441 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,463,320
Previous 4,517,345
1.2%
Holding current value
$441 Million
Previous $513 Million
13.45%
% of portfolio
0.41%
Previous 0.47%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA250MShares$24.7 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.49 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.85 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...